Zimmermann [40] reported that soluble and secreted prostatic acid phosphatase (PAP), an enzyme that has long served as a diagnostic marker for prostate cancer, has a membrane-bound splice variant that exhibits ecto-5′-nucleotidase activity [34]. The gene discussed is NT5E; the disease is prostate cancer.